Suv39h1 Mediates AP-2α-Dependent Inhibition of C/EBPα Expression during Adipogenesis

REFERENCES

• Haslam DW, James WP. 2005. Obesity. Lancet 366:1197–1209. http://dx.doi.org/10.1016/S0140-6736(05)67483-1.
   PubMed Web of Science ®Google Scholar
• Tang QQ, Lane MD. 1999. Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation. Genes Dev. 13:2231–2241. http://dx.doi.org/10.1101/gad.13.17.2231.
   PubMed Web of Science ®Google Scholar
• Tang QQ, Zhang JW, Lane MD. 2004. Sequential gene promoter interactions by C/EBP beta, C/EBP alpha, and PPAR gamma during adipogenesis. Biochem. Biophys. Res. Commun. 318:213–218. http://dx.doi.org/10.1016/j.bbrc.2004.04.017.
   PubMed Web of Science ®Google Scholar
• Tang QQ, Otto TC, Lane MD. 2003. CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc. Natl. Acad. Sci. U. S. A. 100:850–855. http://dx.doi.org/10.1073/pnas.0337434100.
   PubMed Web of Science ®Google Scholar
• Hwang C, Mandrup S, Macdougald OA, Geiman DE, Lane MD. 1996. Transcriptional activation of the mouse obese (ob) gene by CCAAT/enhancer binding protein alpha. Proc. Natl. Acad. Sci. U. S. A. 93:873–877. http://dx.doi.org/10.1073/pnas.93.2.873.
   PubMed Web of Science ®Google Scholar
• Cheneval D, Christy RJ, Geiman D, Cornelius P, Lane MD. 1991. Cell-free transcription directed by the 422 adipose P2 gene promoter: activation by the CCAAT/enhancer binding protein. Proc. Natl. Acad. Sci. U. S. A. 88:8465–8469. http://dx.doi.org/10.1073/pnas.88.19.8465.
   PubMedGoogle Scholar
• Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH, McKnight SL. 1989. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev. 3:1146–1156. http://dx.doi.org/10.1101/gad.3.8.1146.
   PubMed Web of Science ®Google Scholar
• Timchenko NA. 2009. Aging and liver regeneration. Trends Endocrinol. Metab. 20:171–176. http://dx.doi.org/10.1016/j.tem.2009.01.005.
   PubMedGoogle Scholar
• Porse BT, Pedersen TÅ, Xu XF, Lindberg B, Wewer UM, Friis-Hansen L, Nerlov C. 2001. E2F repression by C/EBP alpha is required for adipogenesis and granulopoiesis in vivo. Cell 107:247–258. http://dx.doi.org/10.1016/S0092-8674(01)00516-5.
   PubMed Web of Science ®Google Scholar
• Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsyed SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ. 1995. Impaired energy homeostasis in C/EBP alpha knockout mice. Science 269:1108–1112. http://dx.doi.org/10.1126/science.7652557.
   PubMed Web of Science ®Google Scholar
• Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD, Tenen DG. 2002. Down-regulation and antiproliferative role of C/EBP alpha in lung cancer. Cancer Res. 62:528–534.
   PubMed Web of Science ®Google Scholar
• Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Ji Y, Wu X, Han Z, Hu G. 2001. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res. 61:3176–3181.
   PubMed Web of Science ®Google Scholar
• Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP. 2005. Down-regulation and growth inhibitory role of C/EBP alpha in breast cancer. Clin. Cancer Res. 11:3184–3190. http://dx.doi.org/10.1158/1078-0432.CCR-04-2625.
   PubMed Web of Science ®Google Scholar
• Shim M, Powers KL, Ewing SJ, Zhu S, Smart RC. 2005. Diminished expression of C/EBP alpha in skin carcinomas is linked to oncogenic ras and reexpression of C/EBP alpha in carcinoma cells inhibits proliferation. Cancer Res. 65:861–867.
   PubMedGoogle Scholar
• Paz-Priel I, Friedman A. 2011. C/EBP alpha dysregulation in AML and ALL. Crit. Rev. Oncog. 16:93–102. http://dx.doi.org/10.1615/CritRevOncog.v16.i1-2.90.
   PubMedGoogle Scholar
• Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, Schuller DE, Weber F, Eng C, Plass C. 2007. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Cancer Res. 67:4657–4664. http://dx.doi.org/10.1158/0008-5472.CAN-06-4793.
   PubMedGoogle Scholar
• O'Brien EK, d'Alençon C, Bonde G, Li W, Schoenebeck J, Allende ML, Gelb BD, Yelon D, Eisen JS, Cornell RA. 2004. Transcription factor AP-2 alpha is necessary for development of embryonic melanophores, autonomic neurons and pharyngeal skeleton in zebrafish. Dev. Biol. 265:246–261. http://dx.doi.org/10.1016/j.ydbio.2003.09.029.
   PubMed Web of Science ®Google Scholar
• Schorle H, Meier P, Buchert M, Jaenisch R, Mitchell PJ. 1996. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381:235–238. http://dx.doi.org/10.1038/381235a0.
   PubMed Web of Science ®Google Scholar
• Liu H, Tan BC, Tseng KH, Chuang CP, Yeh CW, Chen KD, Lee SC, Yung BY. 2007. Nucleophosmin acts as a novel AP2 alpha-binding transcriptional corepressor during cell differentiation. EMBO Rep. 8:394–400. http://dx.doi.org/10.1038/sj.embor.7400909.
   PubMed Web of Science ®Google Scholar
• Holt EH, Lane MD. 2001. Downregulation of repressive CUP/AP-2 isoforms during adipocyte differentiation. Biochem. Biophys. Res. Commun. 288:752–758. http://dx.doi.org/10.1006/bbrc.2001.5846.
   PubMed Web of Science ®Google Scholar
• Tang QQ, Otto TC, Lane MD. 2003. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. U. S. A. 100:44–49. http://dx.doi.org/10.1073/pnas.0137044100.
   PubMed Web of Science ®Google Scholar
• Bennett KL, Romigh T, Khelifa A, Teresi RE, Tada Y, Eng Plass CC. 2009. Activator protein 2 alpha (AP2α) suppresses 42kDa C/CAAT enhancer binding protein alpha (p42/C/EBP α) in head and neck squamous cell carcinoma (HNSCC). Int. J. Cancer 124:1285–1292. http://dx.doi.org/10.1002/ijc.24087.
   PubMedGoogle Scholar
• Lehnertz B, Ueda Y, Derijck A, Braunschweig U, Perez-Burgos L, Kubicek S, Chen T, Li E, Jenuwein T, Peters A. 2003. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol. 13:1192–1200. http://dx.doi.org/10.1016/S0960-9822(03)00432-9.
   PubMed Web of Science ®Google Scholar
• Severson PL, Tokar EJ, Vrba L, Waalkes MP, Futscher BW. 2013. Coordinate H3K9 and DNA methylation silencing of ZNFs in toxicant-induced malignant transformation. Epigenetics 8:1080–1088. http://dx.doi.org/10.4161/epi.25926.
   PubMed Web of Science ®Google Scholar
• Rothbart SB, Krajewski K, Nady N, Tempel W, Xue S, Badeaux AI, Barsyte-Lovejoy D, Martinez JY, Bedford MT, Fuchs SM, Arrowsmith CH, Strahl BD. 2012. Association of UHRF1 with methylated H3K9 directs the maintenance of DNA methylation. Nat. Struct. Mol. Biol. 19:1155–1160. http://dx.doi.org/10.1038/nsmb.2391.
   PubMed Web of Science ®Google Scholar
• Cedar H, Bergman Y. 2009. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10:295–304. http://dx.doi.org/10.1038/nrg2540.
   PubMed Web of Science ®Google Scholar
• Ge K. 2012. Epigenetic regulation of adipogenesis by histone methylation. Biochim. Biophys. Acta 1819:727–732. http://dx.doi.org/10.1016/j.bbagrm.2011.12.008.
   PubMed Web of Science ®Google Scholar
• Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, Igarashi M, Youn MY, Takeyama K, Nakamura T, Mezaki Y, Takezawa S, Yogiashi Y, Kitagawa H, Yamada G, Takada S, Minami Y, Shibuya H, Matsumoto K, KatoS. 2007. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat. Cell Biol. 9:1273–1285. http://dx.doi.org/10.1038/ncb1647.
   PubMed Web of Science ®Google Scholar
• Wang L, Xu S, Lee J, Baldridge A, Grullon S, Peng W, Ge K. 2013. Histone H3K9 methyltransferase G9a represses PPARγ expression and adipogenesis. EMBO J. 32:45–59. http://dx.doi.org/10.1038/emboj.2012.306.
   PubMed Web of Science ®Google Scholar
• Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M, Opravil S, Mechtler K, Ponting C, Allis D, Jenuwein T. 2000. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406:593–599. http://dx.doi.org/10.1038/35020506.
   PubMed Web of Science ®Google Scholar
• Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T. 2001. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410:116–120. http://dx.doi.org/10.1038/35065132.
   PubMed Web of Science ®Google Scholar
• Allan RS, Zueva E, Cammas F, Schreiber HA, Masson V, Belz GT, Roche D, Maison C, Quivy J, Almouzni G, Amigorena S. 2012. An epigenetic silencing pathway controlling T helper 2 cell lineage commitment. Nature 487:249–253. http://dx.doi.org/10.1038/nature11173.
   PubMed Web of Science ®Google Scholar
• Mal AK. 2006. Histone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiation. EMBO J. 25:3323–3334. http://dx.doi.org/10.1038/sj.emboj.7601229.
   PubMed Web of Science ®Google Scholar
• Ait-Si-Ali S, Guasconi V, Fritsch L, Yahi H, Sekhri R, Naguibneva I, Robin P, Cabon F, Polesskaya A, Harel-Bellan A. 2004. A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. EMBO J. 23:605–615. http://dx.doi.org/10.1038/sj.emboj.7600074.
   PubMed Web of Science ®Google Scholar
• Vandel L, Nicolas E, Vaute O, Ferreira R, Ait-Si-Ali S, Trouche SD. 2001. Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol. Cell. Biol. 21:6484–6494. http://dx.doi.org/10.1128/MCB.21.19.6484-6494.2001.
   PubMedGoogle Scholar
• Villeneuve LM, Kato M, Reddy MA, Wang M, Lanting L, Natarajan R. 2010. Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes 59:2904–2915. http://dx.doi.org/10.2337/db10-0208.
   PubMedGoogle Scholar
• Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L, Natarajan R. 2008. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc. Natl. Acad. Sci. U. S. A. 105:9047–9052. http://dx.doi.org/10.1073/pnas.0803623105.
   PubMed Web of Science ®Google Scholar
• Jiang MS, Tang QQ, Mclenithan J, Geiman D, Shillinglaw W, Henzel WJ, Lane MD. 1998. Derepression of the C/EBP alpha gene during adipogenesis: identification of AP-2 alpha as a repressor. Proc. Natl. Acad. Sci. U. S. A. 95:3467–3471. http://dx.doi.org/10.1073/pnas.95.7.3467.
   PubMed Web of Science ®Google Scholar
• Loyola A, Tagami H, Bonaldi T, Roche D, Quivy JP, Imhof A, Nakatani Y, Dent SYR, Almouzni SYG. 2009. The HP1α-CAF1-SetDB1-containing complex provides H3K9me1 for Suv39-mediated K9me3 in pericentric heterochromatin. EMBO Rep. 10:769–775. http://dx.doi.org/10.1038/embor.2009.90.
   PubMed Web of Science ®Google Scholar
• Coward WR, Watts K, Feghali-Bostwick CA, Jenkins G, Pang L. 2010. Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis. Mol. Cell. Biol. 30:2874–2886. http://dx.doi.org/10.1128/MCB.01527-09.
   PubMed Web of Science ®Google Scholar
• MacDougald OA, Lane MD. 1995. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64:345–373. http://dx.doi.org/10.1146/annurev.bi.64.070195.002021.
   PubMed Web of Science ®Google Scholar
• Rosen ED, Spiegelman BM. 2000. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16:145–171. http://dx.doi.org/10.1146/annurev.cellbio.16.1.145.
   PubMed Web of Science ®Google Scholar
• Siersbæk R, Nielsen R, Mandrup S. 2012. Transcriptional networks and chromatin remodeling controlling adipogenesis. Trends Endocrinol. Metab. 23:56–64. http://dx.doi.org/10.1016/j.tem.2011.10.001.
   PubMed Web of Science ®Google Scholar
• Linhart HG, Ishimura-Oka K, DeMayo F, Kibe T, Repka D, Poindexter B, Bick RJ, Darlington GJ. 2001. C/EBP alpha is required for differentiation of white, but not brown, adipose tissue. Proc. Natl. Acad. Sci. U. S. A. 98:12532–12537. http://dx.doi.org/10.1073/pnas.211416898.
   PubMed Web of Science ®Google Scholar
• Freytag SO, Paielli DL, Gilbert JD. 1994. Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev. 8:1654–1663. http://dx.doi.org/10.1101/gad.8.14.1654.
   PubMed Web of Science ®Google Scholar
• Musri MM, Carmona MC, Hanzu FA, Kaliman P, Gomis R, Párrizas M. 2010. Histone demethylase LSD1 regulates adipogenesis. J. Biol. Chem. 285:30034–30041. http://dx.doi.org/10.1074/jbc.M110.151209.
   PubMed Web of Science ®Google Scholar
• Teperino R, Schoonjans K, Auwerx J. 2010. Histone methyl transferases and demethylases: can they link metabolism and transcription? Cell. Metab. 12:321–327. http://dx.doi.org/10.1016/j.cmet.2010.09.004.
   PubMed Web of Science ®Google Scholar
• Guo L, Li X, Huang JX, Huang HY, Zhang YY, Qian SW, Zhu H, Zhang YD, Liu Y, Liu Y, Wang KK, Tang QQ. 2012. Histone demethylase Kdm4b functions as a co-factor of C/EBP beta to promote mitotic clonal expansion during differentiation of 3T3-L1 preadipocytes. Cell Death Differ. 19:1917–1927. http://dx.doi.org/10.1038/cdd.2012.75.
   PubMed Web of Science ®Google Scholar
• Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, McKeon C, Darlington GJ, Spiegelman BM. 1999. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 3:151–158. http://dx.doi.org/10.1016/S1097-2765(00)80306-8.
   PubMed Web of Science ®Google Scholar